|Articles|August 1, 2003
TNF Inhibitors: Potential for Use in Dermatology Practice
Author(s)Alice B. Gottlieb, MD, PhD
Psoriasis is a chronic inflammatory disease characterized by well-demarcated red, raised, scaly lesions on any part of the body. The disease often severely impacts patients' mental and physical functioning and quality of life. Signs and symptoms may vary from mild to generalized cutaneous involvement, with or without associated joint disease.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Top 5 Articles of the Week: November 30-December 5
3
The Weekly Roundup: December 1-5
4
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
5















